Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, Jia-Yi, Englund, Elisabet, Holton, Janice L, Soulet, Denis, Hagell, Peter, Lees, Andrew J, Lashley, Tammaryn, Quinn, Niall P +6 more·2008·Nature Medicine

DOI 10.1038/nm1746

Cited by (1,002)

Items 501–600 of 1,002

Release and uptake of pathologic alpha-synuclein
Veselin Grozdanov, Karin M. Danzer · 2018 · Cell and Tissue Research
Review: The future of cell therapies and brain repair: P arkinson's disease leads the way
Géraldine H. Petit, Tomas T. Olsson, Patrik Brundin · 2013 · Neuropathology and Applied Neurobiology
Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle
S. Pablo Sardi, Seng H. Cheng, Lamya S. Shihabuddin · 2015 · Progress in Neurobiology
Binding of α-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes
Juan F. Reyes, Christopher Sackmann, Alana Hoffmann, Per Svenningsson, Jürgen Winkler, Martin Ingelsson, Martin Hallbeck · 2019 · Acta Neuropathologica
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Douglas M. Lopes, Sophie K. Llewellyn, Ian F. Harrison · 2022 · Translational Neurodegeneration
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, Yoshio Hashizume, Kazuko Hasegawa, Yuko Saito, Andrew Robinson, David M. A. Mann, Mari Yoshida, Shigeo Murayama et al. · 2022 · Acta Neuropathologica
Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis
Jennifer T. Lamberts, Erin N. Hildebrandt, Patrik Brundin · 2014 · Neurobiology of Disease
Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases
Tomoya Kon, Masahiko Tomiyama, Koichi Wakabayashi · 2019 · Neuropathology
Mechanisms of alpha-synuclein toxicity: An update and outlook
Inês Caldeira Brás, Mary Xylaki, Tiago F. Outeiro · 2019 · Progress in brain research
Distribution of α-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons
Hiroyuki Sumikura, Masaki Takao, Hiroyuki Hatsuta, Shinji Ito, Yuta Nakano, Akiko Uchino, Akane Nogami, Yuko Saito, Hideki Mochizuki, Shigeo Murayama · 2015 · Acta Neuropathologica Communications
Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine Neurons
David M. Yurek, Anita Fletcher‐Turner, Tomasz H. Kowalczyk, Linas Padegimas, Mark J. Cooper · 2009 · Cell Transplantation
Stem Cells of the Aging Brain
Alexandra M. Nicaise, Cory M. Willis, Stephen J. Crocker, Stefano Pluchino · 2020 · Frontiers in Aging Neuroscience
In vivo models of alpha-synuclein transmission and propagation
Ariadna Recasens, Ayşe Ulusoy, Philipp J. Kahle, Donato A. Di Monte, Benjamin Dehay · 2017 · Cell and Tissue Research
Prion-like seeding and nucleation of intracellular amyloid-β
Tomas T. Olsson, Oxana l. Klementieva, Gunnar K. Gouras · 2018 · Neurobiology of Disease
Corruption and Spread of Pathogenic Proteins in Neurodegenerative Diseases
Lary C. Walker, Harry LeVine · 2012 · Journal of Biological Chemistry
The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy
Marcel Leist, Susanne Bremer, Patrik Brundin, Juergen Hescheler, Agnete Kirkeby, Karl‐Heinz Krause, Peter Pörzgen, Michel Pucéat, Mathias Schmidt, André St. Schrattenholz et al. · 2008 · ALTEX
A brief history of prions
Mark D. Zabel, Crystal Meyerett-Reid · 2015 · Pathogens and Disease
How strong is the evidence that Parkinson's disease is a prion disorder?
Patrik Brundin, Jiyan Ma, Jeffrey H. Kordower · 2016 · Current Opinion in Neurology
An update on immune-based alpha-synuclein trials in Parkinson’s disease
Maha Alfaidi, Roger A. Barker, Wei‐Li Kuan · 2024 · Journal of Neurology
The Parkinson chimera
Andrew John Lees · 2009 · Neurology
Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA
Dominique Bétemps, Jérémy Verchère, Sébastien Brot, Eric Morignat, Luc Bousset, Damien Gaillard, Latifa Lakhdar, Ronald Melki, Thierry Baron · 2014 · Acta Neuropathologica Communications
Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder
Dillon McKenna, John H. Peever · 2017 · Movement Disorders
Animal Model for Prodromal Parkinson’s Disease
Tomoyuki Taguchi, Masashi Ikuno, Hodaka Yamakado, Ryōsuke Takahashi · 2020 · International Journal of Molecular Sciences
Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
Anna Oczkowska, Wojciech P. Kozubski, Margarita Lianeri, Jolanta Dorszewska · 2014 · Current Genomics
The Prion Hypothesis of Parkinson’s Disease
Yaping Chu, Jeffrey H. Kordower · 2015 · Current Neurology and Neuroscience Reports
Deregulation of calcium homeostasis mediates secreted α–synuclein-induced neurotoxicity
Katerina Melachroinou, Maria Xilouri, Evangelia Emmanouilidou, Roser Masgrau, Panagiota Papazafiri, Leonidas Stefanis, Kostas Vekrellis · 2013 · Neurobiology of Aging
Exogenous amyloidogenic proteins function as seeds in amyloid β-protein aggregation
Kenjiro Ono, Ryoichi Takahashi, Tokuhei Ikeda, Mineyuki Mizuguchi, Tsuyoshi Hamaguchi, Masahito Yamada · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Expanding the prion concept to cancer biology: dominant-negative effect of aggregates of mutant p53 tumour suppressor
Jerson Lima Silva, Luciana Pereira Rangel, Danielly C. Ferraz da Costa, Yraima Cordeiro, C. V. de Moura Gallo · 2013 · Bioscience Reports
Replacing Dopamine Neurons in Parkinson’s Disease: How did it happen?
Anders Björklund, Olle Lindvall · 2017 · Journal of Parkinson s Disease
α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson’s disease olfactory bulb
Taylor J. Stevenson, Helen C. Murray, Clinton P. Turner, Richard L. M. Faull, Birger Victor Dieriks, Maurice A. Curtis · 2020 · Scientific Reports
New avenues for Parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota
Lorente-Picón, Marina, Laguna, Ariadna · 2021 · Biomolecules
A simple, versatile and robust centrifugation‐based filtration protocol for the isolation and quantification of α‐synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α‐synuclein research
Senthil T. Kumar, Sonia Donzelli, Anass Chiki, Muhammed Muazzam Kamil Syed, Hilal Ahmed Lashuel · 2020 · Journal of Neurochemistry
Antibodies against Alpha-Synuclein Reduce Oligomerization in Living Cells
Thomas Näsström, Susana A. Gonçalves, Charlotte Sahlin, Eva K. L. Nordström, Valentina Screpanti Sundquist, Lars Lannfelt, Joakim J. E. Bergström, Tiago F. Outeiro, Martin Ingelsson · 2011 · PLoS ONE
α-Synuclein in the olfactory system in Parkinson’s disease: role of neural connections on spreading pathology
Isabel Úbeda‐Bañón, Daniel Saiz‐Sánchez, Carlos de la Rosa‐Prieto, Alino Martı́nez-Marcos · 2013 · Brain Structure and Function
The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future
Stanley Fahn · 2017 · Parkinsonism & Related Disorders
View point: Etiology in Parkinson's disease. Dual hit or spreading intoxication
Heinz Reichmann · 2011 · Journal of the Neurological Sciences
Development of stem cell-based therapy for Parkinson’s disease
Fabin Han, Deborah Baremberg, Junyu Gao, Jing Duan, Xianjie Lu, Nan Zhang, Qingfa Chen · 2015 · Translational Neurodegeneration
Exocytosis and Spreading of Normal and Aberrant α‐Synuclein
Evangelia Emmanouilidou, Kostas Vekrellis · 2016 · Brain Pathology
Immunotherapy in Parkinson’s disease: Current status and future directions
Diptaman Chatterjee, Jeffrey H. Kordower · 2019 · Neurobiology of Disease
Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions
Seiji Kaji, Takakuni Maki, Tomoyuki Ishimoto, Hodaka Yamakado, Ryōsuke Takahashi · 2020 · Translational Neurodegeneration
Assessing fetal nerve cell grafts in Parkinson's disease
Heiko Braak, Kelly Del Tredici · 2008 · Nature Medicine
Regulation of neuronal autophagy and the implications in neurodegenerative diseases
Qian Cai, Dhasarathan Ganesan · 2021 · Neurobiology of Disease
Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson’s disease
Yun Fan, Yunpeng Sun, Wenbo Yu, Youqi Tao, Wencheng Xia, Yiqi Liu, Qinyue Zhao, Yilin Tang, Yi‐Min Sun, Fengtao Liu et al. · 2022 · Structure
Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies
Kostas Vekrellis, Leonidas Stefanis · 2012 · Expert Opinion on Therapeutic Targets
Proteolysis of α‐synuclein fibrils in the lysosomal pathway limits induction of inclusion pathology
Amanda N. Sacino, Mieu Brooks, Paramita Chakrabarty, Kaustuv Saha, Habibeh Khoshbouei, Todd Eliot Golde, Benoit I. Giasson · 2016 · Journal of Neurochemistry
Presence of tau pathology within foetal neural allografts in patients with Huntington’s and Parkinson’s disease
Giulia Cisbani, Alexander Maxan, Jeffrey H. Kordower, Emmanuel Planel, Thomas B Freeman, Francesca Cicchetti · 2017 · Brain
Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
Carlo Scialò, Elena De Cecco, Paolo Manganotti, Giuseppe Legname · 2019 · Viruses
Neural grafting in Parkinson’s disease
Emma L. Lane, Anders Björklund, Stephen B. Dunnett, Christian Winkler · 2010 · Progress in brain research
Generalization of the Prion Hypothesis to Other Neurodegenerative Diseases: An Imperfect Fit
Will C. Guest, Judith M. Silverman, Edward Pokrishevsky, Megan A. O’Neill, Leslie I. Grad, Neil R. Cashman · 2011 · Journal of Toxicology and Environmental Health
Conformational templating of α-synuclein aggregates in neuronal-glial cultures
Amanda N. Sacino, Michael A Thomas, Carolina Ceballos‐Diaz, Pedro E. Cruz, Awilda M. Rosario, Jada M. Lewis, Benoit I. Giasson, Todd Eliot Golde · 2013 · Molecular Neurodegeneration
The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates
Sandesh Neupane, Elena De Cecco, Adriano Aguzzi · 2022 · Journal of Molecular Biology
Causes and Consequences of Degeneration of the Dorsal Motor Nucleus of the Vagus Nerve in Parkinson's Disease
James G. Greene · 2014 · Antioxidants and Redox Signaling
Rewiring the brain with cell transplantation in Parkinson's disease
Afsaneh Gaillard, Mohamed Jaber · 2011 · Trends in Neurosciences
Dopamine Cell Transplantation for Parkinson's Disease: The Importance of Controlled Clinical Trials
Curt R. Freed, Wenbo Zhou, Robert E. Breeze · 2011 · Neurotherapeutics
The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase-2 on Extracellular α-Synuclein Aggregates in Parkinsonian Models
Se Hee Oh, Hana Kim, Hyun-Jung Park, Jin Young Shin, Dong Yeol Kim, Phil Hyu Lee · 2016 · Stem Cells Translational Medicine
Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
Diana F. Lázaro, Maria Angeliki S. Pavlou, Tiago F. Outeiro · 2017 · Experimental Neurology
An Update on Medical and Surgical Treatments of Parkinson’s Disease
Dipali Nemade, Thyagarajan Subramanian, Vikram Shivkumar · 2021 · Aging and Disease
Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease
Esteban Luna, Kelvin C. Luk · 2015 · FEBS Letters
Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration
Stephan N. Witt · 2012 · Molecular Neurobiology
alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson’s disease pathology
Sibylle E. Eisbach, Tiago F. Outeiro · 2013 · Journal of Molecular Medicine
Bone Marrow-Derived Mesenchymal Stem Cell Therapy as a Candidate Disease-Modifying Strategy in Parkinson's Disease and Multiple System Atrophy
Phil Hyu Lee, Hyun Jung Park · 2009 · Journal of Clinical Neurology
α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities
Camilla Lööv, Clemens R. Scherzer, Bradley T. Hyman, Xandra O. Breakefield, Martin Ingelsson · 2016 · Cellular and Molecular Neurobiology
The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease
Charles J. Duyckaerts, Florence Clavaguera, Marie‐Claude Potier · 2019 · Current Opinion in Neurology
Cellular response of human neuroblastoma cells to α-synuclein fibrils, the main constituent of Lewy bodies
Laura Pieri, Philippe Chafey, Morgane Le Gall, Guilhem Clary, Ronald Melki, Virginie Redeker · 2015 · Biochimica et Biophysica Acta (BBA) - General Subjects
Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein
Nolwen L. Rey, Sonia George, Patrik Brundin · 2015 · Neuropathology and Applied Neurobiology
Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns
Shady Rahayel, Bratislav Mišić, Ying‐Qiu Zheng, Zhen-Qi Liu, Alaa Amr Abdelgawad, Nooshin Abbasi, Anna Caputo, Bin Zhang, Angela Lo, Victoria M. Kehm et al. · 2021 · Brain
New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease
Weilin Xie, Oi Wan Wan, Kenny K. K. Chung · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
Bin Xiao, Huck‐Hui Ng, Ryōsuke Takahashi, Eng-King Tan · 2016 · Journal of Neurology Neurosurgery & Psychiatry
Nonhuman Primate Models of Neurodegenerative Disorders
Marina Elena Emborg · 2017 · ILAR Journal
CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson’s Disease
Fatemeh Safari, Gholamreza Hatam, Abbas Behzad‐Behbahani, Vahid Rezaei Tabar, Mazyar Barekati‐Mowahed, Peyman Petramfar, Farzaneh Khademi · 2019 · Cellular and Molecular Neurobiology
Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects
Ratnesh Kumar Singh, Oscar Cuzzani, François Binette, Hal Sternberg, Michael D. West, Igor O. Nasonkin · 2018 · Stem Cell Reviews and Reports
Gut-to-Brain α-Synuclein Transmission in Parkinson’s Disease: Evidence for Prion-like Mechanisms
Merry Chen, Danielle E. Mor · 2023 · International Journal of Molecular Sciences
Gut mucosal cells transfer α-synuclein to the vagus nerve
Rashmi Chandra, Arpine Sokratian, Katherine Ramos Chavez, Stephanie King, Sandip Madhusudan Swain, Joshua C. Snyder, Andrew B. West, Rodger A. Liddle · 2023 · JCI Insight
Interaction between -Synuclein and Other Proteins in Neurodegenerative Disorders
K. A. Jellinger · 2011 · The Scientific World JOURNAL
Aggregated proteins in schizophrenia and other chronic mental diseases
Carsten Korth · 2012 · Prion
What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
Christopher J.R. Dunning, Sonia George, Patrik Brundin · 2013 · Prion
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
Denis Ottolini, Tito Calí, Ildikò Szabó, Marisa Brini · 2016 · Biological Chemistry
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
Tatsunori Maekawa, Toshikuni Sasaoka, Sadahiro Azuma, Takafumi Ichikawa, Heather L. Melrose, Matthew James Farrer, Fumiya Obata · 2016 · BMC Neuroscience
Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease
Dustin J. Covell, John L. Robinson, Rizwan S. Akhtar, Murray Grossman, Daniel A. Weintraub, H. M. Bucklin, Rose M. Pitkin, Dawn M. Riddle, A. Yousef, John Q. Trojanowski et al. · 2017 · Neuropathology and Applied Neurobiology
Combination therapies: The next logical Step for the treatment of synucleinopathies?
Elvira Valera, Eliezer Masliah · 2015 · Movement Disorders
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients
Wojciech Pasławski, Justyna Zarȩba-Pasławska, Xiaoqun Zhang, Katharina Hölzl, Henrik Wadensten, Mohammadreza Shariatgorji, Shorena Janelidze, Oskar Hansson, Lars Forsgren, Per E. Andrén et al. · 2019 · Proceedings of the National Academy of Sciences
Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk
Rakez Kayed, Ulf Dettmer, Sylvain Lesné · 2020 · Journal of Parkinson s Disease
α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice
Norihito Uemura, Nicholas P. Marotta, Jahan Effat Ara, Emily S. Meymand, Bin Zhang, Hiroshi Kameda, Masato Koike, Kelvin C. Luk, John Q. Trojanowski, Virginia M.‐Y. Lee · 2023 · Nature Communications
Iron promotes α‐synuclein aggregation and transmission by inhibiting TFEB ‐mediated autophagosome‐lysosome fusion
Yousheng Xiao, Xiang Chen, Shuxuan Huang, Guihua Li, Mingshu Mo, Li Zhang, Chaojun Chen, Wenyuan Guo, Miaomiao Zhou, Zhuohua Wu et al. · 2018 · Journal of Neurochemistry
PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats
Majken Borup Thomsen, Sara Almeida Ferreira, Anna C. Schacht, Jan Jacobsen, Mette Simonsen, Cristine Betzer, Poul Henning Jensen, David James Brooks, Anne Marlene Landau, Marina Romero‐Ramos · 2020 · Neurobiology of Disease
Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
Elena Giusto, Talene A. Yacoubian, Elisa Greggio, Laura Civiero · 2021 · npj Parkinson s Disease
α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives
Obada M. Alzghool, Guus A.M.S. van Dongen, Elsmarieke van de Giessen, Linda Jeanne Schoonmade, Wissam Beaino · 2022 · Movement Disorders
Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson’s disease
Yunseon Yang, Jae‐Jin Song, Yu Ree Choi, Seong Hoon Kim, Min‐Jong Seok, Noviana Wulansari, Wahyu Handoko Wibowo Darsono, Oh‐Chan Kwon, Mi‐Yoon Chang, Sang Myun Park et al. · 2022 · Proceedings of the National Academy of Sciences
Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials
Maryam Ghasemi, Elham Roshandel, Mozhdeh Mohammadian, Behrouz Farhadihosseinabadi, Parvin Akbarzadehlaleh, Karim Shamsasenjan · 2023 · Stem Cell Research & Therapy
Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson’s Disease
Maria Graciela Cersosimo · 2015 · Gastroenterology Research and Practice
Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases
Carmen I. Nussbaum-Krammer, Richard I. Morimoto · 2014 · Disease Models & Mechanisms
Cell Therapy from Bench to Bedside Translation in CNS Neurorestoratology Era
Hongyun Huang, Lin Chen, Paul R. Sanberg · 2010 · Cell Medicine
Exosomes in Parkinson’s Disease: Current Perspectives and Future Challenges
Lin Yuan, Jiayi Li · 2019 · ACS Chemical Neuroscience
Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease Models
Mikko Airavaara, Ilmari Parkkinen, Julia Konovalova, Katrina Albert, Piotr Chmielarz, Andrii Domanskyi · 2020 · Current Protocols in Neuroscience
Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology
Johannes Burtscher, Jean‐Christophe Copin, João Rodrigues, Senthil T. Kumar, Anass Chiki, Isabelle Guillot de Suduiraut, Carmen Sandi, Hilal Ahmed Lashuel · 2019 · Neurobiology of Aging
GDNF / RET Signaling Pathway Activation Eliminates Lewy Body Pathology in Midbrain Dopamine Neurons
Piotr Chmielarz, Şafak Er, Julia Konovalova, Laura Bandrés, Irena Hlushchuk, Katrina Albert, Anne E. Panhelainen, Kelvin C. Luk, Mikko Airavaara, Andrii Domanskyi · 2020 · Movement Disorders
Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity
Milton H. Werner, C. Warren Olanow · 2021 · Movement Disorders
Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein
Xiaobo Mao, Hao Gu, Donghoon Kim, Yasuyoshi Kimura, Ning Wang, Enquan Xu, Ramhari Kumbhar, Xiaotian Ming, Haibo Wang, Chan Chen et al. · 2024 · Nature Communications
Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α 7 Nicotinic Receptor Drugs
Anna M. Lilja, Linn Malmsten, Jennie Röjdner, Larysa P. Voytenko, Alexei Verkhratsky, Sven Ove Ögren, Agneta K. Nordberg, Amelia Marutle · 2015 · Neural Plasticity
Pax genes during neural development and their potential role in neuroregeneration
Jennifer A. Thompson, Mel R. Ziman · 2011 · Progress in Neurobiology